Revenue
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
OptimizeRx Corp (OPRX)
Price$7.87Cached quote
Net income
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $109.4M | $92.1M | $71.5M | $1.0M | $4.5M | $43.3M | $24.6M | $21.2M | $12.1M | $7.8M | $7.2M | $6.5M | $4.7M | $2.0M | $1.1M | $71,065 |
| Gross profit | $73.6M | $59.4M | $42.9M | $39.0M | $35.6M | $24.1M | $15.4M | $12.2M | $6.0M | $4.3M | $3.6M | $3.3M | $2.8M | $1.9M | — | — |
| Gross margin | 67.25% | 64.45% | 59.98% | 3,801.64% | 789.04% | 55.65% | 62.77% | 57.56% | 49.09% | 55.99% | 49.84% | 50.46% | 60.23% | 94.20% | — | — |
| Research & development | $0 | $0 | — | — | — | $0 | $1.6M | $0 | — | — | — | — | — | — | — | — |
| Operating expenses | $61.9M | $73.1M | $69.3M | $51.3M | $35.3M | $26.2M | $19.1M | $12.0M | $8.1M | $5.9M | $4.2M | $4.3M | $3.1M | $2.3M | $2.6M | $1.9M |
| Operating income | $11.7M | −$13.7M | −$26.4M | −$12.3M | $361,100 | −$2.1M | −$3.7M | $180,132 | −$2.1M | −$1.6M | −$597,407 | −$1.0M | −$267,536 | −$454,922 | −$1.5M | −$1.8M |
| Operating margin | 10.69% | −14.88% | −36.91% | −1,199.10% | 7.99% | −4.93% | −15.02% | 0.85% | −17.56% | −20.40% | −8.27% | −15.78% | −5.72% | −22.87% | −130.81% | −2,597.95% |
| EBITDA | $16.0M | −$9.4M | −$24.0M | −$10.3M | $2.3M | −$59,431 | −$2.4M | $496,634 | −$1.8M | −$1.3M | −$263,457 | −$761,988 | −$73,745 | −$267,818 | −$1.3M | −$1.8M |
| EBITDA margin | 14.64% | −10.18% | −33.56% | −1,001.83% | 51.51% | −0.14% | −9.80% | 2.34% | −14.89% | −17.37% | −3.65% | −11.72% | −1.58% | −13.46% | −117.74% | −2,513.62% |
| Net income | $5.1M | −$20.1M | −$17.6M | −$11.4M | $378,079 | −$2.2M | −$3.1M | $226,344 | −$2.1M | −$1.5M | −$595,140 | −$1.0M | −$267,290 | −$454,553 | −$2.1M | −$2.0M |
| Net profit margin | 4.69% | −21.83% | −24.56% | −1,115.95% | 8.37% | −5.10% | −12.78% | 1.07% | −17.35% | −19.86% | −8.24% | −15.77% | −5.71% | −22.85% | −190.80% | −2,827.02% |
| Basic EPSper basic share | $0.28 | -$1.10 | -$1.03 | -$0.64 | $0.02 | -$0.15 | -$0.23 | $0.02 | -$0.21 | -$0.15 | -$0.06 | -$0.12 | -$0.06 | — | — | — |
| Diluted EPSper diluted share | $0.27 | -$1.10 | -$1.03 | -$0.64 | $0.02 | -$0.15 | -$0.23 | $0.02 | -$0.21 | -$0.15 | — | -$0.12 | -$0.06 | — | — | — |
Owners
Reported shareholders
8.01%of listed shares
Whetstone Capital Advisors, LLC1.51M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
Whetstone Capital Advisors, LLC | 8.01%1.51M shares |
ROYCE & ASSOCIATES LP | 5.78%1.09M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 3.71%699.6K shares |
KENNEDY CAPITAL MANAGEMENT LLC | 3.42%644.15K shares |
RICE HALL JAMES & ASSOCIATES, LLC | 3.37%633.84K shares |
BLAIR WILLIAM & CO/IL | 3.23%607.93K shares |
FEBBO WILLIAM J | ≈3.19%600.85K shares |
AQR CAPITAL MANAGEMENT LLC | 3.10%583.96K shares |
DIMENSIONAL FUND ADVISORS LP | 2.54%477.69K shares |
BlackRock, Inc. | 2.36%445.38K shares |
Lang James Paul | ≈2.30%433.84K shares |
Parkman Healthcare Partners LLC | 1.86%350.35K shares |
Bullseye Asset Management LLC | 1.37%258.31K shares |
AWM Investment Company, Inc. | 1.28%240.42K shares |
GEODE CAPITAL MANAGEMENT, LLC | 1.10%207.35K shares |
Silvestro Stephen L | ≈0.98%185.29K shares |
VANGUARD PORTFOLIO MANAGEMENT LLC | 0.90%169.54K shares |
RENAISSANCE TECHNOLOGIES LLC | 0.89%167.7K shares |
MARSHALL WACE, LLP | 0.86%162.19K shares |
P.A.W. CAPITAL CORP | 0.85%160K shares |
Percentages use 18.83M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Dec 19, 2025Form 4 | Stelmakh EdwardChief Finance & Strat Officer | SellCommon Stock | 1.4K | $13.51 | $18.8K | 126.8K |
| Oct 3, 2025Form 4 | Silvestro Stephen LChief Executive Officer | SellCommon Stock | 1.6K | $18.75 | $30.4K | 188.9K |
| Aug 28, 2025Form 4 | Spangler Patrick DDirector | SellCommon Stock | 11.1K | $17.49 | $194.5K | 44.2K |
| Mar 14, 2025Form 4 | Lang James PaulDirector | BuyCommon Stock | 321.4K | $7.60 | $2.44M | 389.5K |
| Dec 12, 2024Form 4 | FEBBO WILLIAM JCEO | BuyCommon Stock | 20.0K | $5.01 | $100.2K | 601.3K |